These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7617100)

  • 1. Ubiquitin in dialysis amyloidosis.
    Okada M; Miyazaki S; Hirasawa Y
    Nephron; 1995; 70(1):125-6. PubMed ID: 7617100
    [No Abstract]   [Full Text] [Related]  

  • 2. [Amyloidosis of the dialysis patient].
    van Ypersele de Strihou C
    Bull Mem Acad R Med Belg; 1988; 143(10-12):456-65; discussion 465-7. PubMed ID: 3077074
    [No Abstract]   [Full Text] [Related]  

  • 3. Age and dialysis-related amyloidosis.
    Baldrati L; Docci D; Tomidei G; Capponcini C; Neri L; Feletti C
    Nephron; 1994; 67(1):120. PubMed ID: 8052356
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnostic and therapeutic aspects of dialysis-related amyloidosis].
    Kopeć J
    Przegl Lek; 2006; 63(7):567-72. PubMed ID: 17203811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, morphologic, biochemical, and immunohistochemical aspects of dialysis-associated amyloidosis.
    Hampl H; Lobeck H; Bartel-Schwarze S; Stein H; Eulitz M; Linke RP
    ASAIO Trans; 1987; 33(3):250-9. PubMed ID: 3675951
    [No Abstract]   [Full Text] [Related]  

  • 6. Behavior of beta 2-microglobulin (B2-m) serum levels in uremic patients.
    Mioli VA; Balestra E; Bibiano L; Dellabella S; Fanciulli E; Gaffi G; Perilli A; Petroselli F; Ricciatti AM; Carletti P
    Int J Artif Organs; 1994 Nov; 17(11):576-80. PubMed ID: 7744516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes.
    Floege J; Koch KM
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S52-6. PubMed ID: 7923985
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-flux hemodialysis postpones clinical manifestation of dialysis-related amyloidosis.
    Küchle C; Fricke H; Held E; Schiffl H
    Am J Nephrol; 1996; 16(6):484-8. PubMed ID: 8955759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biocompatibility study on cuprophane and polysulphone dialysers.
    Taraba I; Polner K; Makó J
    Nephrol Dial Transplant; 1991; 6 Suppl 3():22-5. PubMed ID: 1775261
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of dialysis membranes on the development of dialysis-related amyloidosis.
    Miura Y; Ishiyama T; Okada M; Nakamaru T; Morita H
    Contrib Nephrol; 1995; 112():129-36. PubMed ID: 7554984
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of dialysate buffer on serum beta-2-microglobulin levels in chronic hemodialysis.
    Küchle C; Lang SM; Schiffl H
    Nephron; 1998; 79(1):99-100. PubMed ID: 9609469
    [No Abstract]   [Full Text] [Related]  

  • 13. [Amyloidosis associated with dialysis].
    Fernández E; Torras J
    Med Clin (Barc); 1990 Mar; 94(12):451-3. PubMed ID: 2195253
    [No Abstract]   [Full Text] [Related]  

  • 14. [Amyloidosis in patients under hemodialysis. Therapeutic strategy].
    Dueymes JM; Vernier I
    Presse Med; 1987 Jun; 16(25):1245-6. PubMed ID: 2955382
    [No Abstract]   [Full Text] [Related]  

  • 15. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].
    Czyz W; Szepietowski T
    Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloidosis and its relationship to different dialysers.
    van Ypersele de Strihou C; Floege J; Jadoul M; Koch KM
    Nephrol Dial Transplant; 1994; 9 Suppl 2():156-61. PubMed ID: 8065608
    [No Abstract]   [Full Text] [Related]  

  • 17. [Beta 2-microglobulin and dialysis-related amyloidosis].
    Gejyo F
    Rinsho Byori; 2001 Mar; 49(3):244-8. PubMed ID: 11307323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemofiltration and the middle molecule.
    Henderson LW
    Blood Purif; 1999; 17(4):175-7. PubMed ID: 10494018
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-2-microglobulin levels of dialysis patients with renal amyloidosis secondary to familial Mediterranean fever.
    Sungur C; Ozen S; Ozkuyumcu C; Akpolat T; Yasavul U; Turgan C; Caglar S
    Nephron; 1994; 68(1):152. PubMed ID: 7991035
    [No Abstract]   [Full Text] [Related]  

  • 20. [Countermeasure for patients with amyloidosis due to hemodialysis].
    Gejo F
    Nihon Naika Gakkai Zasshi; 1995 Oct; 84(10):1673-7. PubMed ID: 8537723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.